Dr. Navneet Kaur, MD

Dr. Kaur practices at Sutter Roseville Medical Center in Roseville, California, part of Sutter Health.

Dr. Kaur's NPI, 1720448749, was assigned on March 3, 2016. Dr. Kaur holds California license A173744.

Dr. Kaur's primary practice is Sutter Roseville Medical Center, at One Medical Plaza, Roseville, CA 95661 in Placer County. The practice phone is (916) 781-1000. Dr. Kaur also practices at Sutter Roseville Medical Center, 1 Medical Plz, Roseville, CA 95661.

Dr. Kaur's primary practice is Sutter Roseville Medical Center in Roseville, California, part of Sutter Health. Dr. Kaur is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Kaur to 3 more hospitals, 1 group practice or clinic, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaur practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kaur's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Kaur's licenses on file in 2 states: California and Florida.

CMS data shows 291 Medicare services from Dr. Kaur across 3 procedure codes in 2024, for 133 Medicare patients. Medicare paid $40,083 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 133 Medicare patients who saw Dr. Kaur in 2024. The largest group is 75 to 84, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaur's median patient age at 67, with 50% women.

In 2024, Dr. Kaur wrote 107 Medicare Part D claims for 34 patients. 53% of them were for generic drugs. CMS names the drug for 49 of them, across 3 drugs with 11 or more claims each, at $10,909 in total drug cost. In 2023, CMS named 38 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Kaur for performance year 2024, reported as part of a group. Dr. Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 33 general payments to Dr. Kaur from 15 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Inari Medical, Inc. paid the most, $391.